Annex

United Kingdom

In Annex I to Directive 91/414/EEC, the following entry is added at the end of the table:

$\{[α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} \{[α — L — Fuc p — (1→2) — β — D — Gal p — (1→2) — α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} — D — Glc - ol$ ’
Further details on identity and specification of active substances are provided in the review report.
No	Common name, Identification numbers	IUPAC name	Purity^f1	Entry into force	Expiration of inclusion	Specific provisions
‘304	Heptamaloxyloglucan CAS No 870721-81-6 CIPAC No Not available	Full IUPAC name in footnote^f2 Xyl p: xylopyranosyl Glc p: glucopyranosyl Fuc p: fucopyranosyl Gal p: galactopyranosyl Glc-ol: glucitol	≥ 780 g/kg The impurity Patulin must not exceed 50 μg/kg in the technical material.	1 June 2010	31 May 2020	PART A Only uses as plant growth regulator may be authorised. PART B For the implementation of the uniform principles of Annex VI, the conclusions of the review report on heptamaloxyloglucan, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 27 November 2009 shall be taken into account.

$\{[α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} \{[α — L — Fuc p — (1→2) — β — D — Gal p — (1→2) — α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} — D — Glc - ol$ ’

Further details on identity and specification of active substances are provided in the review report.

Common name, Identification numbers

IUPAC name

Purity^f1

Entry into force

Expiration of inclusion

Specific provisions

‘304

Heptamaloxyloglucan

CAS No

870721-81-6

CIPAC No

Not available

Full IUPAC name in footnote^f2

Xyl p: xylopyranosyl
Glc p: glucopyranosyl
Fuc p: fucopyranosyl
Gal p: galactopyranosyl
Glc-ol: glucitol

≥ 780 g/kg

The impurity Patulin must not exceed 50 μg/kg in the technical material.

1 June 2010

31 May 2020

PART A

Only uses as plant growth regulator may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on heptamaloxyloglucan, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 27 November 2009 shall be taken into account.

Annotations

Footnotes

f1: Further details on identity and specification of active substances are provided in the review report.
f2: $\{[α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} \{[α — L — Fuc p — (1→2) — β — D — Gal p — (1→2) — α — D — Xyl p — (1→6)] — β — D — Glc p — (1→4)\} — D — Glc - ol$ ’